Drug intelligence / Profile preview

modified sodium hyaluronate gel

Development stage: Unknown
Lead developer: Bloomage Biotech
Modality: Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration: Injection

Overview

Modified sodium hyaluronate gel is an injectable biomaterial primarily used as a dermal filler for aesthetic and medical purposes. It is a modified form of sodium hyaluronate, a naturally occurring glycosaminoglycan, often enhanced through crosslinking to improve its stability, cohesiveness, rheological properties, and in-vivo retention time. When injected, it physically augments tissue volume and attracts water, providing hydration and structural support. This product is being developed by companies like Bloomage Biotechnology Corporation Limited for indications such as shaping the nose and correcting infraorbital depression.

Other names: Hyaluronan SodiumHyaluronan

Beyond the preview

Go deeper on modified sodium hyaluronate gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on modified sodium hyaluronate gel.

Explore the full profile